KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹0.07 Cr | ₹0.28 Cr | ₹0.38 Cr | ₹0.39 Cr | ₹0.41 Cr |
What is the latest Long Term Provisions ratio of KILITCH DRUGS (INDIA) ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹0.07 Cr |
Mar2022 | ₹0.28 Cr |
Mar2021 | ₹0.38 Cr |
Mar2020 | ₹0.39 Cr |
Mar2019 | ₹0.41 Cr |
How is Long Term Provisions of KILITCH DRUGS (INDIA) Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹0.07 Cr | -75.27 | |
Mar2022 | ₹0.28 Cr | -27.82 | |
Mar2021 | ₹0.38 Cr | -1.80 | |
Mar2020 | ₹0.39 Cr | -6.05 | |
Mar2019 | ₹0.41 Cr | - |
Compare Long Term Provisions of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹579.7 Cr | 3% | -7.7% | 114.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 3% |
-7.7% |
114.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses